Indiva’s Ontario Cannabis Store Supply Agreement a Testament to Quality
February 11th, 2019
Exclusive, News, Top News
INDIVA Limited (TSX-V:NDVA), a London, Ontario licensed supplier of high quality medical-grade cannabis, announced February 8th that it has inked its first supply agreement with the Ontario Cannabis Retail Corporation, consisting of two strains of pre-rolls for sale through the Ontario Cannabis Store.
The products will be manufactured and shipped from Indiva’s London, Ontario facility and become available on https://ocs.ca/ and to OCS’ wholesale clients starting in April 2019.
Niel Marotta, President and CEO of Indiva, said, “We are thrilled to be one of the first licensed producers that will have products on OCS shelves in time for the grand opening of all Ontario stores April 1st. I’m very thankful for our team’s hard work in getting Indiva to this milestone.”
The Ontario Cannabis Store is the only legal seller of recreational cannabis in Ontario, and only buys cannabis products from producers licensed by Health Canada, which have been tested and verified for quality, so becoming one of its first suppliers is somewhat of a badge of honour.
Indiva’s cannabis flower is produced using aeroponics, a soil-less process in which plant roots are suspended in air and misted with nutrients, producing larger yields and a much cleaner product while at the same time, being environmentally friendly. Its London facility includes four state of the art grow rooms, and a $13.7 million, fully-funded, expansion is currently underway, which will result in a 40,000 square foot facility with up to eight more rooms for cultivation, extraction, product manufacturing, and even a retail space.
Indiva is positioning itself as a global brand recognized for the high quality of its cannabis products and excellent client services. The Indiva brand currently includes pre-rolls, tinctures, and accessories, but a range of other products has already been developed in anticipation of the legalization of cannabis derivatives (vapes, edibles, concentrates) in Canada, expected in October. The company went public in December of 2017, and has $24 million on the balance sheet with a $46 million market cap, and made a number of strategic moves throughout the past year to further diversify its brand.
In April, Indiva formed a 50/50 joint venture with Nevada-based Bhang Corporation, an award-winning producer of THC/ CBD concentrates and infused edibles, to be managed by Indiva, enabling the manufacture and sale of Bhang products in Canada, as well export to growing international markets. Bhang’s product line includes the most awarded line of chocolate bars in the world, as well as gummies, oral sprays, isolates, vapes and vape cartridges, and a range of accessories. The acquisition of a 4.9% stake in Bhang also gives Indiva its first entry into the legal US adult-use market.
Also in April, Indiva purchased a 14% stake in and exclusive license agreement with DeepCell Industries – the Seattle-based technology development company focusing on material science, microfluidics, and cannabinoid molecule discoveries – giving it the exclusive right to manufacture and market DeepCell’s line of innovative products produced through its patented Crystal Fusion technology.
Crystal Fusion mechanically fuses cannabinoids with sugar or salt, producing a “flexible edible” consumers can use to infuse their food and beverages with THC or CBD while seasoning. The resulting products are sold as Ruby Cannabis Sugar and Ruby Cannabis Salt, and all Bhang products and Ruby Sugars and Salts will be cross-branded in Canada – “Powered By INDIVA”.
A Community-Minded Company
Indiva has set itself apart through its community engagement, supporting first responders and veterans, chronic illness support organizations, and other initiatives, and gives twenty cents from every gram of Indiva-branded flower and oil sold to assist mental and physical health initiatives and organizations across Canada.
Pete Young , the company’s Master Grower, is passionate about making cannabis available to Canadians suffering from chronic illnesses, respected for his activism. He founded the London Compassion Society in the mid-90’s, and is a devoted advocate of patients’ rights.
Investors would do well to keep Indiva on their radar as it continues to transition from a supplier of medical cannabis to a manufacturer and retailer of high margin cannabis-derived and pre-packaged products, partners with innovative companies like Bhang and Deepcell, and expands into emerging foreign markets.
For more information, please visit: https://www.indiva.com/
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.